LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis

Photo from wikipedia

PurposeTo report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab.MethodsCase report.ResultsA 45-year-old woman previously treated for candida chorioretinitis was presented with… Click to show full abstract

PurposeTo report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab.MethodsCase report.ResultsA 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT.ConclusionsBevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.

Keywords: choroidal neovascularization; treatment; candida chorioretinitis

Journal Title: International Ophthalmology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.